Showing results (181-190 of 629) with videos related to
Sort By:
Pageof 63
The American Journal of Cardiology|September 9, 2008
Prognostic significance of troponin T elevation in patients without chest painErik R Carlson, Robert F Percy, Dominick J Angiolillo, et al.Circulation. Cardiovascular Interventions|April 16, 2024
Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary InterventionAlessandro Spirito, Sriya L Krishnan, Davide Capodanno, et al.European Heart Journal|December 17, 2021
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trialsMattia Galli, Stefano Benenati, Francesco Franchi, et al.Circulation|January 12, 2019
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionFrancesco Franchi, Fabiana Rollini, Andrea Rivas, et al.JACC. Basic to Translational Science|June 2, 2020
Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic TestingFrancesco Franchi, Fabiana Rollini, Jose Rivas, et al.JACC. Cardiovascular Interventions|March 26, 2016
Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 StudyFrancesco Franchi, Gabriel Todd Faz, Fabiana Rollini, et al.Journal of the American College of Cardiology|March 12, 2016
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 TrialRobert F Storey, Dominick J Angiolillo, Marc P Bonaca, et al.Circulation|March 13, 2018
Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 StudyFrancesco Franchi, Fabiana Rollini, Jose Rivas Rios, et al.Thrombosis and Haemostasis|March 17, 2017
Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes statusMark R Thomas, Dominick J Angiolillo, Marc P Bonaca, et al.Journal of the American College of Cardiology|November 19, 2013
Impact of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: insights from the CAPRIE trial (Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events)José L Ferreiro, Deepak L Bhatt, Masafumi Ueno, et al.Pageof 63